The present invention provides a compound of formula I:
or a pharmaceutically acceptable salt or mixtures thereof. These compounds are inhibitors of protein kinases, particularly inhibitors of GSK mammalian protein kinase, and more particularly inhibitors of GSK-3 mammalian protein kinase. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of utilizing those compounds and compositions in the treatment of various protein kinase mediated disorders.
本发明提供了公式I的化合物:或其药学上可接受的盐或混合物。这些化合物是蛋白激酶的
抑制剂,特别是GSK哺乳动物蛋白激酶的
抑制剂,更特别是GSK-3哺乳动物蛋白激酶的
抑制剂。本发明还提供了包括本发明化合物的药学上可接受的组合物以及利用这些化合物和组合物治疗各种蛋白激酶介导的疾病的方法。